MERSYNDOL FORTE paracetamol 450 mg / codeine phosphate hemihydrate 30 mg / doxylamine succinate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mersyndol forte paracetamol 450 mg / codeine phosphate hemihydrate 30 mg / doxylamine succinate 5 mg tablet blister pack

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 450 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; magnesium stearate; purified talc; stearic acid; povidone; pregelatinised maize starch; crospovidone - indications as at 9 june 2020: mersyndol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mevadol forte paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 450 mg; codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose - mevadol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Codeine Linctus BP Malta - English - Medicines Authority

codeine linctus bp

lcm limited linthwaite laboratories, huddersfield, hd7 5qh, united kingdom - codeine phosphate - oral solution - codeine phosphate 15 mg/5ml - cough and cold preparations